Search Results - "Alvim, Renata G F"

Intradermal Immunization of SARS-CoV-2 Original Strain Trimeric Spike Protein Associated to CpG and AddaS03 Adjuvants, but Not MPL, Provide Strong Humoral and Cellular Response in Mice by Firmino-Cruz, Luan, Dos-Santos, Júlio Souza, da Fonseca-Martins, Alessandra Marcia, Oliveira-Maciel, Diogo, Guadagnini-Perez, Gustavo, Roncaglia-Pereira, Victor A, Dumard, Carlos H, Guedes-da-Silva, Francisca H, Vicente Santos, Ana C, Alvim, Renata G F, Lima, Tulio M, Marsili, Federico F, Abreu, Daniel P B, Rossi-Bergmann, Bartira, Vale, Andre M, Filardy, Alessandra D'Almeida, Silva, Jerson Lima, de Oliveira, Andrea Cheble, Gomes, Andre M O, de Matos Guedes, Herbert Leonel

“…Despite the intramuscular route being the most used vaccination strategy against SARS-CoV-2, the intradermal route has been studied around the globe as a…”
Get full text

Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform by Alvim, Renata G.F., Itabaiana, Ivaldo, Castilho, Leda R.

“…Zika virus (ZIKV) was first detected in Brazil in 2015 and then rapidly spread to more than 80 countries in Africa, Asia and the Americas. ZIKV infection was…”
Get full text

Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study by Grenfell, Rafaella F. Q., Almeida, Nathalie B. F., Filgueiras, Priscilla S., Corsini, Camila A., Gomes, Sarah V. C., de Miranda, Daniel A. P., Lourenço, Adelina J., Martins-Filho, Olindo A., de Oliveira, Jaquelline G., Teixeira-Carvalho, Andrea, Campos, Guilherme R. F., Nogueira, Mauricio L., Alves, Pedro Augusto, Fernandes, Gabriel R., Castilho, Leda R., Lima, Tulio M., de Abreu, Daniel P. B., Alvim, Renata G. F., Silva, Thaís Bárbara de S., Jeremias, Wander de J., Otta, Dayane A., Campi-Azevedo, Ana Carolina

“…BackgroundEffective and safe vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical to controlling the COVID-19 pandemic…”
Get full text

Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum by Dos-Santos, Júlio Souza, Firmino-Cruz, Luan, da Fonseca-Martins, Alessandra Marcia, Oliveira-Maciel, Diogo, Perez, Gustavo Guadagnini, Roncaglia-Pereira, Victor A, Dumard, Carlos H, Guedes-da-Silva, Francisca H, Santos, Ana C Vicente, Leandro, Monique Dos Santos, Ferreira, Jesuino Rafael Machado, Guimarães-Pinto, Kamila, Conde, Luciana, Rodrigues, Danielle A S, Silva, Marcus Vinicius de Mattos, Alvim, Renata G F, Lima, Tulio M, Marsili, Federico F, Abreu, Daniel P B, Ferreira, Jr, Orlando C, Mohana Borges, Ronaldo da Silva, Tanuri, Amilcar, Souza, Thiago Moreno L, Rossi-Bergmann, Bartira, Vale, André M, Silva, Jerson Lima, de Oliveira, Andréa Cheble, Filardy, Alessandra D'Almeida, Gomes, Andre M O, de Matos Guedes, Herbert Leonel

“…The SARS-CoV-2 pandemic has had a social and economic impact worldwide, and vaccination is an efficient strategy for diminishing those damages. New adjuvant…”
Get full text

Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection by Corsini, Camila A, Filgueiras, Priscilla S, Almeida, Nathalie BF, Miranda, Daniel AP de, Gomes, Sarah VC, Lourenço, Adelina Junia, Bicalho, Cecilia MF, Assis, Jessica V de, Amorim, Raquel NH, Silva, Raphael A, Vilela, Raquel VR, Lima, Tulio M, Abreu, Daniel PB de, Alvim, Renata GF, Castilho, Leda R, Martins-Filho, Olindo A, Otta, Dayane A, Grenfell, Rafaella FQ

“…The COVID-19 pandemic has caused a severe global health and economic crisis, with significant consequences for human mortality and morbidity. Therefore, there…”
Get full text

Process intensification for the production of yellow fever virus‐like particles as potential recombinant vaccine antigen by Alvim, Renata G. F., Lima, Túlio M., Silva, Jerson L., Oliveira, Guilherme A. P., Castilho, Leda R.

“…Yellow fever (YF) is a life‐threatening viral disease endemic in parts of Africa and Latin America. Although there is a very efficacious vaccine since the…”
Get full text

From a recombinant key antigen to an accurate, affordable serological test: Lessons learnt from COVID-19 for future pandemics by Alvim, Renata G F, Lima, Tulio M, Rodrigues, Danielle A S, Marsili, Federico F, Bozza, Vicente B T, Higa, Luiza M, Monteiro, Fabio L, Abreu, Daniel P B, Leitão, Isabela C, Carvalho, Renato S, Galliez, Rafael M, Castineiras, Terezinha M P P, Travassos, Leonardo H, Nobrega, Alberto, Tanuri, Amilcar, Ferreira, Jr, Orlando C, Vale, André M, Castilho, Leda R

“…Serological tests detect antibodies generated by infection or vaccination, and are indispensable tools along different phases of a pandemic, from early…”
Get full text

The immunodominant antibody response to Zika virus NS1 protein is characterized by cross-reactivity to self by Cavazzoni, Cecilia B, Bozza, Vicente B T, Lucas, Tostes C V, Conde, Luciana, Maia, Bruno, Mesin, Luka, Schiepers, Ariën, Ersching, Jonatan, Neris, Romulo L S, Conde, Jonas N, Coelho, Diego R, Lima, Tulio M, Alvim, Renata G F, Castilho, Leda R, de Paula Neto, Heitor A, Mohana-Borges, Ronaldo, Assunção-Miranda, Iranaia, Nobrega, Alberto, Victora, Gabriel D, Vale, Andre M

“…Besides antigen-specific responses to viral antigens, humoral immune response in virus infection can generate polyreactive and autoreactive antibodies. Dengue…”
Get full text

Conformational stability of SARS-CoV-2 glycoprotein spike variants by Arruda, Hiam R.S., Lima, Tulio M., Alvim, Renata G.F., Victorio, Fernanda B.A., Abreu, Daniel P.B., Marsili, Federico F., Cruz, Karen D., Marques, Mayra A., Sosa-Acosta, Patricia, Quinones-Vega, Mauricio, de S. Guedes, Jéssica, Nogueira, Fábio C.S., Silva, Jerson L., Castilho, Leda R., de Oliveira, Guilherme A.P.

“…The severe acute respiratory syndrome spread worldwide, causing a pandemic. SARS-CoV-2 mutations have arisen in the spike, a glycoprotein at the viral envelope…”
Get full text

Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency by Cunha, Luis Eduardo R., Stolet, Adilson A., Strauch, Marcelo A., Pereira, Victor A.R., Dumard, Carlos H., Gomes, Andre M.O., Monteiro, Fábio L., Higa, Luiza M., Souza, Patrícia N.C., Fonseca, Juliana G., Pontes, Francisco E., Meirelles, Leonardo G.R., Albuquerque, José W.M., Sacramento, Carolina Q., Fintelman-Rodrigues, Natalia, Lima, Tulio M., Alvim, Renata G.F., Marsili, Federico F., Caldeira, Marcella Moreira, Zingali, Russolina B., de Oliveira, Guilherme A.P., Souza, Thiago M.L., Silva, Alexandre S., Muller, Rodrigo, Rodrigues, Daniela del Rosário Flores, Jesus da Costa, Luciana, Alves, Arthur Daniel R., Pinto, Marcelo Alves, Oliveira, Andréa C., Guedes, Herbert L.M., Tanuri, Amilcar, Castilho, Leda R., Silva, Jerson L.

“…We used the recombinant trimeric spike (S) glycoprotein in the prefusion conformation to immunize horses for the production of hyperimmune globulins against…”
Get full text